Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study

Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study

Background: The chronic kidney disease (CKD) population, including kidney transplant recipients (KTRs) and subjects on renal replacement therapy, is particularly vulnerable to unfavorable outcomes from chronic hepatitis C (CHC). Currently, there are oral direct-acting antiviral agents (DAAs) availab...

Full description

Bibliographic Details
Main Authors: Paulina Czarnecka, Kinga Czarnecka, Olga Tronina, Teresa Bączkowska, Aleksandra Wyczałkowska-Tomasik, Magdalena Durlik, Katarzyna Czerwinska
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Journal of Clinical Medicine
Subjects:
hepatitis C infection (HCV)
chronic infection
liver fibrosis
direct-acting antiviral agents (DAA)
occult hepatitis C infection
treatment efficacy
Online Access:https://www.mdpi.com/2077-0383/12/10/3513

Internet

https://www.mdpi.com/2077-0383/12/10/3513

Similar Items